SCHEMBL9800231

SCHEMBL9800231

CN1C(=O)CC2(CCCC2)CC1O

nearest known ligand 0.38

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 1/20 0.36
HTR1A P08908 5/20 0.32
ADRA1B P35368 3/20 0.32
HSD11B1 P28845 1/20 0.31
ADRA1D P25100 1/20 0.31
ADRA1A P35348 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24987391 0.79 SMN1; SMN2 (0.37) SMN1; SMN2HTR1AADRA1BADRA1A
SCHEMBL24987392 0.78 SMN1; SMN2 (0.36) SMN1; SMN2HTR1AADRA1BADRA1A
SCHEMBL24987393 0.76 SMN1; SMN2 (0.38) SMN1; SMN2HTR1AADRA1BADRA1A
SCHEMBL24987395 0.76 SMN1; SMN2 (0.33) SMN1; SMN2HTR1AADRA1B
SCHEMBL25914140 0.75 SMN1; SMN2 (0.34) SMN1; SMN2HTR1AADRA1BADRA1DADRA1A
SCHEMBL9800243 0.75 MAPT (0.34) HTR1A
SCHEMBL25914144 0.74 SMN1; SMN2 (0.33) SMN1; SMN2HTR1AADRA1BADRA1A
SCHEMBL25914137 0.71 SMN1; SMN2 (0.31) SMN1; SMN2
SCHEMBL9800221 0.71 HTR1A (0.32) SMN1; SMN2HTR1AADRA1BADRA1DADRA1A
SCHEMBL24987390 0.71 MEN1 (0.30)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0417143-A1 CYCLIC LACTAMS FOR CHOLESTEROL AND ATHEROSCLEROSIS CONTROL THE UPJOHN COMPANY (US) 1991-03-20 EP claimed
WO-1989011856-A2 CYCLIC LACTAMS FOR CHOLESTEROL AND ATHEROSCLEROSIS CONTROL THE UPJOHN COMPANY (US) 1989-12-14 WO claimed
EP-0417143-A1 CYCLIC LACTAMS FOR CHOLESTEROL AND ATHEROSCLEROSIS CONTROL THE UPJOHN COMPANY (US) 1991-03-20 EP disclosed
WO-1989011856-A2 CYCLIC LACTAMS FOR CHOLESTEROL AND ATHEROSCLEROSIS CONTROL THE UPJOHN COMPANY (US) 1989-12-14 WO disclosed